264 related articles for article (PubMed ID: 31896811)
1. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
2. The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.
Wils LJ; Poell JB; Peferoen LAN; Evren I; Brouns ER; de Visscher JGAM; van der Meij EH; Brakenhoff RH; Bloemena E
J Oral Pathol Med; 2023 Nov; 52(10):930-938. PubMed ID: 37749621
[TBL] [Abstract][Full Text] [Related]
3. [Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression].
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Ned Tijdschr Tandheelkd; 2021 Feb; 128(2):103-111. PubMed ID: 33605260
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
7. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients.
Liu W; Wang YF; Zhou HW; Shi P; Zhou ZT; Tang GY
BMC Cancer; 2010 Dec; 10():685. PubMed ID: 21159209
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
[TBL] [Abstract][Full Text] [Related]
11. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
[TBL] [Abstract][Full Text] [Related]
12. Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.
Evren I; Brouns ER; Wils LJ; Poell JB; Peeters CFW; Brakenhoff RH; Bloemena E; de Visscher JGAM
Oral Oncol; 2020 Nov; 110():105014. PubMed ID: 33038723
[TBL] [Abstract][Full Text] [Related]
13. Oral premalignant lesions: from a clinical perspective.
Amagasa T; Yamashiro M; Uzawa N
Int J Clin Oncol; 2011 Feb; 16(1):5-14. PubMed ID: 21225307
[TBL] [Abstract][Full Text] [Related]
14. Grading oral epithelial dysplasia: analysis of individual features.
Tilakaratne WM; Sherriff M; Morgan PR; Odell EW
J Oral Pathol Med; 2011 Aug; 40(7):533-40. PubMed ID: 21501232
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
[TBL] [Abstract][Full Text] [Related]
16. Oral epithelial dysplasia and the development of invasive squamous cell carcinoma.
Lumerman H; Freedman P; Kerpel S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Mar; 79(3):321-9. PubMed ID: 7621010
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.
Wils LJ; Poell JB; Brink A; Evren I; Brouns ER; de Visscher JGAM; Bloemena E; Brakenhoff RH
Clin Cancer Res; 2023 Feb; 29(3):602-613. PubMed ID: 36449687
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
19. [Oral medicine 8. Leukoplakia of the oral mucosa].
Schepman KP; van der Meij EH; de Visscher JG
Ned Tijdschr Tandheelkd; 2013; 120(7-8):384-90. PubMed ID: 23923441
[TBL] [Abstract][Full Text] [Related]
20. [White lesions of the oral mucosa: leukoplakia].
de Visscher JGAM; van der Meij EH
Ned Tijdschr Tandheelkd; 2023 May; 130(5):232-236. PubMed ID: 37157988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
